Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to welcome Dr James G. Wright to NDORMS, as Senior Clinical Research Fellow focusing on Paediatric Orthopaedics and Evidence-based Orthopaedics.

James Wright

We are delighted to welcome Dr James G. Wright to NDORMS, as Senior Clinical Research Fellow focusing on Paediatric Orthopaedics and Evidence-based Orthopaedics.

A prominent orthopaedic surgeon, former Vice President Medical, Surgeon in Chief and Chief of Perioperative Services at the Hospital for Sick Children in Toronto, Canada, Dr Wright has a strong commitment to research with more than 230 peer-reviewed publications, including Lancet, Science, New England Journal of Medicine, Journal of the American Medical Association, and the British Medical Journal. Dr.  Wright has, for the past 15 years, held the Robert B. Salter Chair of Paediatric Surgical Research, awarded to outstanding individuals who are responsible for world-leading research and academic activities in their fields.

As Senior Scientist in the Child Health Evaluative Sciences Program in The SickKids Research Institute (a program he previously led for 5 years), his research has focused on the development of measures to evaluate surgical therapy, randomised clinical trials, and evaluating unmet need and disparity in the use of orthopaedic procedures.

Dr. Wright is also an advocate for better medical education; in 1997, he won the Robert B. Salter Excellence in Orthopaedic Education Award and is active in both graduate student and medical education.

Speaking of his move to Oxford, Dr Wright says: “I have long admired and am thrilled by the opportunity to join the distinguished and world-renowned clinical and research faculty at the University of Oxford. I am excited to use Oxford as center for pediatric orthopedic clinical trials and to work with the well-established research group to tackle the next challenge beyond evidence based orthopaedics, changing surgeon behaviour.”

Head of Department Professor Andrew Carr said: “I am delighted that Professor Wright is moving to Oxford. He has an international reputation as an inspirational leader in his field. His clinical and research expertise will be a valuable addition to programmes in clinical trials and paediatric orthopaedics.”

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8th October 2026.

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

NIHR fellowship to support national trial evaluating rehabilitation after kneecap dislocation

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Professor Afsie Sabokbar retires after more than 30 years at NDORMS

Botnar Institute Director of Graduate Studies, Professor Afsie Sabokbar, is retiring after more than 30 years at NDORMS.

Researchers funded to cure – rather than manage – inflammatory disease

Researchers from the Kennedy Institute of Rheumatology will join international partners in a bid to transform how chronic inflammatory disease is treated.